[Celiac disease: correlation of different diagnostic methods (author's transl)]

Current diagnostic approaches for celiac disease rely on a mix of biochemical and imaging techniques. Prior research has shown that no single test offers complete diagnostic certainty. This uncertainty drives the need for comparative analysis of available tools. Established knowledge includes the role of intestinal biopsy as the gold standard. However, non-invasive alternatives remain limited in accuracy. No prior work had resolved the comparative effectiveness of xylosemia, IgA levels, steatorrhea, and X-ray imaging. This gap motivated a study to evaluate these four diagnostic methods. The research aimed to clarify which tests most reliably correlate with biopsy results. By analyzing a large cohort, the study sought to inform clinical decision-making.

The study aimed to assess the reliability of four diagnostic methods for celiac disease. It focused on their correlation with biopsy findings, which are considered definitive. The researchers wanted to determine which tests most accurately reflect mucosal atrophy. They also sought to identify false positives and negatives across these methods. A key goal was to evaluate whether a combination of tests could improve diagnostic accuracy. The study addressed the clinical challenge of diagnosing celiac disease without biopsy. By comparing test results with biopsy data, the authors aimed to guide diagnostic protocols. Their work sought to inform when to use non-invasive tests alongside biopsy.

The study evaluated four diagnostic tests in a cohort of 100 individuals. Eighty had biopsy-confirmed small intestinal mucosa atrophy. Twenty had normal biopsy results. The four tests included xylosemia, serum IgA levels, steatorrhea, and X-ray imaging. Researchers compared test outcomes with biopsy findings to assess accuracy. They calculated the percentage of cases where each test aligned with biopsy results. False positives and negatives were documented for each method. The analysis focused on identifying which tests most reliably detected mucosal atrophy. The study also examined whether a combination of tests could reduce false results.

Xylosemia showed the strongest correlation with biopsy results at 90%. Serum IgA levels followed closely at 87% accuracy. X-ray imaging of the digestive tract had an 86% correlation. Steatorrhea was the least accurate at 59%. In cases with normal biopsies, xylosemia was abnormal in 70% of cases. Serum IgA levels exceeded 2 delta in 35% of these cases. Steatorrhea was abnormal in 29% of non-celiac cases. X-ray imaging remained the only test without false diagnoses in this group.

The authors concluded that no single test reliably detects celiac disease. Biopsy remains essential for definitive diagnosis. Xylosemia, serum IgA, and steatorrhea each have significant false results. X-ray imaging showed the highest accuracy in non-celiac cases. The study found that combining three tests reduces false negatives. None of the 80 celiac cases had all three tests falsely negative. The authors propose using these three tests alongside biopsy. Their findings suggest that a multi-test approach improves diagnostic reliability.